A New Model for Studying Eosinophil Migration Across Cultured Intestinal Epithelial Monolayers

Journal of Pediatric Gastroenterology and Nutrition

Volumn 39, Issue 1, 2004, Pages 56-63

  Michail, Sonia ^a   Abernathy, Frank ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Eosinophils; HL 60; Intestinal epithelium; Migration

Indexed keywords

BETA CHEMOKINE; EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CELL MOTION; CELL STRAIN HL 60; CYTOLOGY; DRUG EFFECT; EOSINOPHIL; FLUORESCENCE; HUMAN; INTESTINE MUCOSA; LEUKOCYTE COUNT; PHYSIOLOGY; TIME;

CELL MOVEMENT; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; EOSINOPHILS; FLUORESCENCE; HL-60 CELLS; HUMANS; INTESTINAL MUCOSA; LEUKOCYTE COUNT; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PLATELET ACTIVATING FACTOR; TIME FACTORS;

EID: 9944260644     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-200407000-00012     Document Type: Article

References (33)

1. Rothenberg ME. Gastrointestinal eosinophils in health and disease. Adv Immunol 2001:78:291-328.
2. D'Netto MA. Allergic gastroenteropathy in preterm infants. J Pediatr 2000:137(4):480-6.
3. Fox VL. Gastrointestinal bleeding in infancy and childhood. Gastroenterol Clin North Am 2000;29(1):37-66.
4. Thomazzi SM. Role of nitric oxide on in vitro human eosinophil migration. Biochem Pharmacol 2001;62(10):1417-21.
5. Resnick MB, Colgan SP, Parkos CA, et al. Human eosinophils migrate across an intestinal epithelium in response to platelet-activating factor. Gastroenterology 1995;108:409-16.
6. Kato M, Kephart GM, Talley NJ, et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998;252:418-25.
7. Mir A. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am J Gastroenterol 2002;97(6):1452-7.
8. Fischkoff SA, Pollak A, Gleich GJ, et al. Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med 1984;160:179.
9. Fischkoff SA. Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions. Leuk Res 1988;12:679.
10. Fischkoff SA, Brown GE, Pollak A. Synthesis of eosinophil associated enzymes in HL-60 promyelocytic leukemia cells. Blood 1986;68:185.
11. Blackshaw AJ, Levison DA. Eosinophilic infiltrates of the gastrointestinal tract. J Clin Pathol 1986;39:1-7.
12. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Ann Rev Med 1993;44:85-101.
13. Michail S, Abernathy F. Transepithelial migration of HL-60 differentiated eosinophils is induced by enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr 2002;35:423.
14. Michail S, Abernathy F. A novel model for studying transepithelial migration of eosinophils across a cultured intestinal epithelium. Gastroenterology 2002;122(4):A151.
15. Hua J, Hasebe T, Someya A, et al. Evaluation of the expression of NADPH oxidase components during maturation of HL-60 clone 15 cells to eosinophilic lineage. Inflamm Res 2001;50(3):156-67.
16. Howe RS, Fischkoff SA, Rossi RM, et al. Chemotactic capabilities of HL-60 human myeloid leukemia cells differentiated to eosinophils. Exp Hematol 1990;18:299-303.
17. Knol EF, Tackey F, Tedder TF, et al. Comparison of human eosinophil and neutrophil adhesion to endothelial cells under non-static conditions. Role of L-selectin. J Immunol 1994;153:2161-7.
18. Hashizume K, Hatanaka Y, Fukuda I, et al. N-acetyl-L-cysteine suppresses constitutive expression of CD11a/LFA-1alpha protein in myeloid lineage. Leuk Res 2002;26(10):939-44.
19. Rubio G, Ferez X, Mora A, et al. Beta 1 integrin triggering affects leukemic cell line sensitivity to natural killer cells. Cancer Immunol Immunother 2002;51(3):130-8.
20. Chuang KP, Tsai WS, Wang YJ, et al. Superoxide activates very late antigen-4 on an eosinophil cell line increases cellular binding to vascular cell adhesion molecule-1. Eur J Immunol 2003;33(3):645-55.
21. Kobzdej MM, Leppanen A, Ramachandran V, et al. Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. Blood 2002;100(13):4485-94.
22. Long M, Zhao H, Huang KS, et al. Kinetic measurements of cell surface E-selectin/carbohydrate ligand interaction. Ann Biomed Eng 2001;29(11):935-46.
23. Anton P, O'Connell J, O'Connell D, et al. Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP). Gut 1998;42:374-9.
24. Panaro MA, Mitolo Y. Cellular responses to FMLP challenging: a mini-review. Immunopharmacol Immunotoxicol 1999;21:397-419.
25. Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor: evidence of 1-0-alkyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979;254:9355.
26. Lee M, Winslow C, eds. New Horizons in Platelet-Activating Factor Research. New York: Plenum; 1987.
27. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem 1990;265:17381.
28. Kroegel C, Yukawa T, Dent G, et al. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989;142:3518.
29. Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-7.
30. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449-56.
31. Kampen GT, Stafford S, Adachi T, et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinase. Blood 2000;95:1911-7.
32. Adachi T. Myosin light chain kinase mediates eosinophil chemotaxis in a mitogen-activated protein kinase-dependent manner. J Allergy Clin Immunol 2003,111(1):113-6.
33. Neote K, DiGeorgeo D, Mak JY, et al. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993;72:415.